| 25/456 |
Locum Spend for Agency Doctors: March 2025 - May 2025 |
| 25/455 |
Stress-Related Diagnoses for NHS Patients (2022 – 2025) |
| 25/454 |
Maternity & Obstetric Care 2024 - Patient Complaints & Agency Staff |
| 25/452 |
New Biologic & Targeted Medications - Gastroenterology |
| 25/451 |
Market for Bank or Agency Management Services |
| 25/446 |
Gamma Camera & SPECT/CT (Contract Detials) |
| 25/445 |
2024 Stillbirth Statistics |
| 25/444 |
Drug Treatments - Oncology RCC |
| 25/443 |
Intravitreal Treatments |
| 25/441 |
Handling Palantir FOI requests |
| 25/440 |
Endoscopy Decontamination Unit |
| 25/438 |
NHS Acute: Risk Assessment in Domestic Abuse |
| 25/436 |
Drug Treatments - Migraine |
| 25/434 |
Drug Treatments of Lung Cancer |
| 25/432 |
Solar Energy Usage and Future Plans |
| 25/429 |
Lead for Regional Anaesthesia |
| 25/428 |
Drug Treatments - Biologics (Gastro) |
| 25/426 |
Staff Policy Regarding use of Fragranced Products |
| 25/425 |
HSCN (Health and Social Care Network) and Connectivity |
| 25/424 |
Contact Details |
